Sunday, August 2, 2020

Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India

DCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.

from Latest News https://www.dnaindia.com/india/report-coronavirus-vaccine-dcgi-gives-nod-to-serum-oxford-for-phase-2-3-clinical-trials-in-india-2835633
Share:

0 comments:

Post a Comment

Blog Archive

Definition List

Unordered List

Support